Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The use of disease-modifying agents in multiple sclerosis--by the Canadian Network of MS Clinics.

× No keyword cloud information.

7 in total

1. Escalating immunotherapy of multiple sclerosis.

Authors: Peter Rieckmann; Anthony Traboulsee; Virginia Devonshire; Joel Oger
Journal: Ther Adv Neurol Disord Date: 2008-11 Impact factor: 6.570

2. Information processing and magnetic resonance imaging indices of brain pathology in multiple sclerosis.

Authors: Antonina Omisade; John D Fisk; Raymond M Klein; Matthias Schmidt; Sultan Darvesh; Virender Bhan
Journal: Int J MS Care Date: 2012

3. Intra-individual Variability as a Measure of Information Processing Difficulties in Multiple Sclerosis.

Authors: Magdalena Wojtowicz; Lindsay I Berrigan; John D Fisk
Journal: Int J MS Care Date: 2012

4. Intra-individual variability in information processing speed reflects white matter microstructure in multiple sclerosis.

Authors: Erin L Mazerolle; Magdalena A Wojtowicz; Antonina Omisade; John D Fisk
Journal: Neuroimage Clin Date: 2013-06-28 Impact factor: 4.881

5. When to initiate disease-modifying drugs for relapsing remitting multiple sclerosis in adults?

Authors: Mona Alkhawajah; Joel Oger
Journal: Mult Scler Int Date: 2011-05-17

Review 6. Development of oral immunomodulatory agents in the management of multiple sclerosis.

Authors: Richard Nicholas; Paolo Giannetti; Ali Alsanousi; Tim Friede; Paolo A Muraro
Journal: Drug Des Devel Ther Date: 2011-05-10 Impact factor: 4.162

7. The effect of scheduled antibody testing on treatment patterns in interferon-treated patients with multiple sclerosis.

Authors: Edward Fox; Barbara Green; Clyde Markowitz; Ronald Murray; Andrew D Goodman; Stephen J Glenski; Pippa Loupe; Jo Nita Cogburn
Journal: BMC Neurol Date: 2014-04-04 Impact factor: 2.474

7 in total